NCT03853811

Brief Summary

This study will examine the use of a novel customized Ankle Foot Orthosis (AFO), created using 3D scanning, with children being treated for clubfoot. The AFO is inserted in the standard Mitchell shoe during bracing, following Ponseti casting. The investigators hypothesize that following Ponseti casting, the implementation of customized AFOs with Ponseti bracing will improve patient compliance and functional outcomes as well as lead to fewer relapses in comparison to the standard bracing with Mitchell shoes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 17, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2022

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

2.9 years

First QC Date

January 20, 2019

Last Update Submit

April 2, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Assessment of Functional Outcomes of Bracing Treatment Using Dimeglio Scores

    Assessed using changes in Dimeglio Scores. The Dimeglio scoring system uses a 20-point system (20 being the most severe and \<5 as benign) by assessing four parameters. The severity of the deformity is then assigned a grade of I-IV with IV being the most severe. (A score of \<5 is given a grade of I, =5\<10 is grade II, =10\<15 is grade III, and =15\<20 is grade IV)

    Collected when visit where cast is applied, visit when cast is removed, then at 2 weeks, 12 weeks, 24 weeks of bracing

  • Time Spent in Brace to Assess Brace Compliance

    Measured with sensor placed in Mitchell shoe

    24 weeks (from start of bracing treatment)

  • Assessing Treatment Factors that Impact Brace Compliance with Parental Questionnaires

    Assessing reasons for poor compliance with parental questionnaires. The questionnaires ask questions about casting, occurrences of skin lesions, history of treatments, bracing information, reasons for not using brace, and brace slippage

    24 weeks (from start of bracing treatment)

Secondary Outcomes (1)

  • Assessing Demographic Factors that Impact Brace Compliance with Parental Questionnaire

    24 weeks (from start of bracing treatment)

Study Arms (2)

Mitchell Shoe + AFO

EXPERIMENTAL

Group will receive standard Mitchell shoes along with the custom orthotic insert.

Device: Ankle Foot Orthosis (AFO)

Standard Mitchell Shoe (Control - Standard Treatment)

NO INTERVENTION

Group will receive standard treatment which includes bracing with standard Mitchell shoes (no custom orthotic). Patients would receive this treatment regardless of study participation.

Interventions

The intervention group will receive the custom AFO to use in their standard Mitchell shoe.

Mitchell Shoe + AFO

Eligibility Criteria

AgeUp to 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • less than 12 months old (no age minimum)
  • no neuromuscular disease involved
  • treated by Ponseti casting
  • idiopathic bilateral or unilateral clubfoot
  • no other congenital foot deformity
  • no previous open surgeries to treat the deformity

You may not qualify if:

  • patients with prior surgical treatment
  • not treated by Ponseti casting
  • an underlying syndrome
  • neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Clubfoot

Condition Hierarchy (Ancestors)

TalipesFoot Deformities, AcquiredFoot DeformitiesMusculoskeletal DiseasesFoot Deformities, CongenitalLower Extremity Deformities, CongenitalLimb Deformities, CongenitalMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Scott Van Valin, MD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 20, 2019

First Posted

February 26, 2019

Study Start

April 17, 2019

Primary Completion

March 2, 2022

Study Completion

March 2, 2022

Last Updated

April 11, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations